Key takeaways Vyvanse is FDA-approved for ADHD and binge eating disorder but not for weight loss
Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro
While the safety profile of GLP-1s is well-established in the treatment of diabetes, their use for weight loss is newer
Some researchers have highlighted post-treatment study findings that have shown that people tend to suffer from a high risk of weight regain after stopping these drugs
If your provider recommends a compounded formulation, understanding proper semaglutide reconstitution or tirzepatide reconstitution becomes essential
Preservation of muscle and bone mass The adverse effects of weight reduction on muscle and bone massparticularly among individuals with insufficient physical activity or protein intake or at older ages [59,149]have highlighted the interrelated priorities to preserve muscle mass, muscle quality, bone mass, and physical function
